Minimally invasive esophageal surgery-standard of care-our experience
DOI:
https://doi.org/10.18203/2320-6012.ijrms20150325Keywords:
MIES, Cancer esophagus, GEJ, Nodal dissection, MarginsAbstract
Background: Surgery is the most effective treatment for the resectable esophageal cancer of the middle & lower third and gastro-esophageal junction (GEJ) tumors. We hereby scrutinise our experience in minimally invasive esophageal surgery (MIES) to evaluate its safety and efficacy as an oncosurgical procedure.
Methods: The study included99consecutive patients. Depending on the location of the tumor, either thoracoscopic transthoracic esophagectomy (TTE) in prone position or laparoscopic transhiatal esophagectomy (THE) was planned. 2 field comprehensive nodal dissection were part of both the surgical procedures.
Results: 05 patients were excluded, 18 were inoperable and 12 had open surgery.
64 underwent MIES (THE-37, TTE-27), Male: Female-31:33. Nodal Harvest (nodes): THE-14.27, TTE-14.77. Margins (cm): THE-proximal (P) - 6.70, distal (D) -2.51, TTE: (P)-5.41, (D)-5.11.
30 days Morbidity (26): cervical leak-05, left vocal cord palsy-05, tracheostomy-03, respiratory insufficiency-03, aspiration-01, chyle leak-01, exploratory laparotomy-01, cardiac-02, stroke-01, surgical emphysema -01, abdominal wound Infection -03
30 days Mortality (1) –pulmonary embolus. Operative time (minutes): THE-234, TTE-322. Blood loss (ml/patient): THE-265, TTE-380. Hospital stays (days): THE-7.3, TTE-10.
Conclusions: 79% of properly selected & evaluated cases underwent MIES, with one Mortality and 26 events of morbidity. 6% required conversion. The procedure detected inoperability in 16% cases. The nodal yield, status of margins, operative time, blood loss and hospital stay indicates that MIES has a future to become a standard of care in the treatment of esophageal cancers.
Metrics
References
Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence mortality and prevalence across five continents. J Clin Oncol. 2006;24:2137–50.
Cherian JV, Sivaraman R, Muthusamy AK, et al. Carcinoma of the esophagus in Tamil Nadu (South India): 16-year trends from a tertiary center. J Gastrointestin Liver Dis. 2007;16:245-9.
Butler N, Collins S, Memon B, Memon MA. Minimally invasive oesophagectomy- current status and future direction. Surg Endosc. 2011;25:2071–83.
Verhage RJJ, Hazebroek EJ, Boone J, et al. Minimally invasive surgery compared to open procedures in esophagectomy for cancer: a systematic review of the literature. Minerva Chirurgica. 2009;64:135–46.
Biere SS, van Berge Henegouwen MI, Maas KW, et al. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet. 2012;19(379):1887-92.
DeGraaf GW, Ayantunde AA, Parsons SL, et al. The role of staging laparoscopy in oesophagogastric cancers. Eur J SurgOncol. 2007;33:988-92.
Veeramachaneni NK, Zoole JB, Decker PA, et al. Lymph node analysis in esophageal resection: American College of Surgeons Oncology Group Z0060 trial. Ann Thorac Surg. 2008;86:418-21.
Law S, Arcilla C, Chu KM, et al. The significance of histologically infiltrated resection margin after esophagectomy for esophageal cancer. Am J Surg. 1998;176:286-90.
Barbour AP, Rizk NP, Gonen M, et al. Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome. Ann Surg. 2007;246:1-8.
Rizk NP, Bach PB, Schrag D, Bains MS, et al. The impact of complications on outcomes after resection of for esophageal and gastro esophageal junction carcinoma. J Am Coll Surg. 2010;198:42–50.
Sharma S. Management of Complications of Radical Esophagectomy Indian J Surg Oncol. 2013;4(2):105-11.
Inoue J, Ono R, Makiura D, et al. Prevention of postoperative pulmonary complications through intensive preoperative respiratory rehabilitation in patients with esophageal cancer. Dis Esophagus.
Downloads
Published
How to Cite
Issue
Section
